Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 14, 2023
Patent Application Number
16069012
Date Filed
January 11, 2017
Patent Citations
Patent Citations Received
Patent Primary Examiner
CPC Code
The invention provides compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone (ABDNAZ), including formulations containing autologous whole blood and ABDNAZ that can be rapidly administered to a patient by intravenous infusion without any significant pain at the site of infusion.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
